TELETRADER News

Japan plans giving remdesivir special approval - Abe

EPA-EFE/JOHN G. MABANGLO

Japan's Prime Minister Shinzo Abe said on Monday that the country is planning to grant special approval for using Gilead Sciences drug remdesivir to treat the coronavirus, according to Kyodo.

The news comes several days after it was reported remdesivir failed to improve the condition of 158 COVID-19 patients during its first randomized clinical trial in China. Furthermore, the drug, developed by Gilead as an unsuccessful treatment for Ebola, caused significant side effects in some patients.

Breaking the News / NP